Highlights Relief Therapeutics Holding SA OTC Markets

Equities

RLFTY

US7595JP3044

Market Closed - OTC Markets Other stock markets 11:35:27 17/05/2024 pm IST			5-day change	1st Jan Change
1.43 ^USD	+0.70%		0.00%	-31.90%

08/05	Relief Therapeutics Restructures Management Team, Creates New Roles	MT
08/05	Relief Therapeutics Announces Executive Changes	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Relief Therapeutics Holding SA Reports Earnings Results for the Full Year Ended December 31, 2023	30/04	CI
Relief Therapeutics' FY23 Loss Widens; Revenue Edges Down	30/04	MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday	22/03	MT
Sector Update: Health Care	22/03	MT
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product	22/03	MT
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike	22/03	MT
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE	22/03	CI
Relief Therapeutics CEO to Leave; Interim Successor Takes Over	22/11	MT
Relief Therapeutics Meets Outstanding ADR Requirement for Nasdaq Listing	10/23/10	MT
Relief Therapeutics Holding AG Reports Earnings Results for the Half Year Ended June 30, 2023	15/23/15	CI
Relief Therapeutics Posts Wider H1 Loss; Revenue Down	15/23/15	MT
Relief Therapeutics Sells License for Urea Cycle Disorder Drug to Acer Therapeutics	31/23/31	MT
Relief Therapeutics Holding AG Announces New Exclusive Definitive License Agreement for OLPRUVA(TM) (ACER-001) with Acer Therapeutics	31/23/31	CI
Relief Therapeutics Announces Extension of Distribution Agreement for Pku Golike®? in the U.S. with Pentec Health	19/23/19	CI
Relief Therapeutics Extends US Distribution Deal with Pentec Health for PKU GOLIKE	19/23/19	MT
SIX Group Makes Index Adjustments Following Review	12/23/12	MT
Relief Therapeutics Entrusts Middle Eastern Distribution of PKU GOLIKE to World Orphan Drug Alliance	23/23/23	MT
Swiss Bourse Fines Relief Therapeutics for Delayed Publication of Ad Hoc Announcements	13/23/13	MT
Relief Therapeutics Laboratory Receives Swissmedic Certification for Good Manufacturing Practice	15/23/15	MT
Reverse Split: 1 of 400	05/23/05	FA

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Relief Therapeutics Holding SA OTC Markets

Equities

RLFTY

US7595JP3044

Highlights

Filters